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Arthropod-borne diseases such as malaria and dengue virus afflict billions of people worldwide 
imposing major economic and social burdens. Control of such pathogens is mainly performed 
by vector management and treatment of affected individuals with drugs. The failure of these 
conventional approaches due to emergence of insecticide-resistant insects and drug-resistant 
parasites demonstrate the need of novel and efficacious control strategies to combat these 
diseases. Genetic modification (GM) of mosquito vectors to impair their ability to be infected and 
transmit pathogens has emerged as a new strategy to reduce transmission of many vector-borne 
diseases and deliver public health gains. Several advances in developing transgenic mosquitoes 
unable to transmit pathogens have gained support, some of them attempt to manipulate the 
naturally occurring endogenous refractory mechanisms, while others initiate the identification 
of an exogenous foreign gene which disrupt the pathogen development in insect vectors. 
Heterologous expression of transgenes under a native or heterologous promoter is important for 
the screening and effecting of the transgenic mosquitoes. The effect of the transgene on mosquito 
fitness is a crucial parameter influencing the success of this transgenic approach. This review 
examines these two aspects and describes the basic research work that has been accomplished 
towards understanding the complex relation between the parasite and its vector and focuses on 
recent advances and perspectives towards construction of transgenic mosquitoes refractory to 
vector-borne disease transmission.
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1. Introduction
  Mosquitoes are vectors of serious human infectious 
diseases, such as malaria, dengue and yellow fever. With 
an increased concern about insecticide resistance, genetic 
modification of mosquitoes has emerged as a new strategy 
to control mosquito-borne diseases. Three interconnected 
research objectives must be achieved before a disease 
control strategy involving the release of transgenic vectors 
could be attempted. Firstly, genes which encode traits 
that render the vector refractory to a particular pathogen 
must be identified. Secondly, methods to introduce and 
express these genes in insects in a stable, heritable fashion 
must be developed. Thirdly, a means for spreading these 
genes to high frequency in natural vector populations must 
be accomplished. There are two major lines of research 
being pursued in the search for genes which will render 
an individual vector refractory to a particular pathogen. 
Some researchers are attempting to identify and manipulate 
naturally occurring refractoriness mechanisms, while others 
are seeking to identify foreign genes which encode proteins 
that will disrupt the development of the pathogen in the 
insect host.
  In recent years, the prospect of using transgenic 
mosquitoes has rapidly gained strength[1,2]. This advance 
in application of transgenic mosquitoes is attributed to the 
identification of transposable elements for mosquito germ 
line transformation, the finding of suitable transformation 
markers such as fluorescent proteins[3], the standardization 
of microinjection techniques[4,5], the characterization of 
promoters that can drive the expression of foreign genes 
in a tissue- and stage-specific manner[6-9] and the 
identification and characterization of effector molecules 
that can interfere with the development of parasites in the 
invertebrate host[10-13] . 
  One of the central issues in the development of transgenic 
mosquitoes is the heterologous expression of transgenes. 
Heterologous expression is referred to as the foreign or 
synthesized genes, such as enhanced green fluorescent 
protein (EGFP), salivary gland- and Midgut-binding 
peptide1 (SM1) and single chain antibody fragments 
(scFv), expressed in transgenic mosquitoes under a native 
or heterologous promoter (Vitellogenin promoter or 3伊
P3), or an endogenous gene, such as Cecropin A (CecA) 
or Defensin A (DefA), expressed ectopically under a 
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heterologous promoter in a manner different from its native 
gene. Heterologous expression is crucial for the screening 
and effecting of the transgenic mosquitoes. Here, we 
reviewed the relevant progress in the field of heterologous 
expression in transgenic mosquitoes and proposed some 
points need to be attended in the future study.
2. Transgenic vectors
  Generally, transgenic vectors consist of three functional 
parts, i.e. selective cassette, effective cassette and 
transposable element (Figure 1). Studies on these three 
aspects have gained much progress in the past decade and 
reliable techniques have been developed. At present, the 
most often used selective markers are EGFP and DsRed, 
commonly driven by a tissue specific promoter like 3伊
P3, the eye-specific promoter. After transformation, the 
positive transgenic mosquitoes can be easily screened 
under the fluorescent microscope by observing the specific 
fluorescence in specific area. Effector molecules include 
natural (Cecropin A, Defensin A) or synthetic antimicrobial 
peptides (SM1), antibodies against parasite or mosquito 
midgut proteins with toxic or inhibitory effect (1C3, 
Phospholipase A2). Those genes are usually driven by a 
promoter to be expressed in a specific manner, conferring 
tissue-, stage- or sex- specificity. The promoters under 
intensive study include carboxypeptidase (CP), adult 
peritrophic matrix protein 1 (Aper1), vitellogenin (VG) 
or antiplatelet protein (Aapp), which direct heterologous 
expression in midgut, fat body (both Aper1 and VG) and 
salivary gland, respectively. 
Figure 1. Transgenic Vectors.
3伊P3: Drosophila melanogaster Pax-6 eye-specific enhancer-
promoter; actinP: actin5C promoter from Drosophila melanogaster; 
beta2-tubP: beta2-tubulin promoter; EGFP: enhanced green 
fluorescent protein gene; DsRed: red fluorescent protein gene; CFP: 
cyan fluorescent protein gene; Luc: luciferase gene from Photinus 
pyralis; CP: carboxypeptidase promoter; VP: vitellogenin promoter; 
AappP: anopheline antiplatelet protein; Aper1P: adult peritrophic 
matrix protein promoter; PLA2: phospholipase A2; SM1: salivary 
gland- and midgut-binding peptide 1; scFv: single chain antibody 
fragment.
  The transposable elements such as Hermes, Minos 
and piggyBac have been used successfully for germ line 
transformation in more than a dozen species of insects. 
However, integration sites are randomly distributed in the 
genome and transgene expression may be site-specific. Most 
recently, it was reported that chimeric Mos1 and piggyback 
transposases resulted in site-directed integration[14]. This 
technology has the potential to minimize non-targeted 
integration events for development of genetically modified 
mosquitoes. Another site-specific integration system based 
on a viral integrase streptomyces phage phi C31 has been 
proven to increase integration efficiency by up to 7.9-
fold[15]. The ability to efficiently target transgenes to specific 
chromosomal locations and the potential to integrate very 
large transgenes has broaden research on many medical 
and economically important species. The integrations 
driven by nonautonomous transposable elements are stable 
in the absence of suitable transposase, however, such 
absence cannot always be guaranteed. This problem could 
be solved by a method of post-integration elimination of 
all transposon sequences which was carried out in the pest 
insect Medfly, Ceratitis capitata[16]. The resulting insertions 
lack transposon sequences and are therefore impervious to 
transposase activity.
3. Expression characteristics
  The heterologous expression in transgenic mosquitoes 
can be evaluated at transcriptional and translational levels. 
Heterologous genes or endogenous genes are transcribed to 
mRNA under the regulation of varied promoter; this process 
can be analyzed by northern blot, RT-PCR or quantitative 
real-time RT-PCR (qRT-PCR). Further analysis includes 
hybridization in-situ to examine RNA distribution and 
accumulation in specific tissues, gene amplification methods 
for detecting the presence and abundance of transcription 
products, the sequencing analysis of genomic DNA and 
cDNAs for intron identification and processing of primary 
transcripts. More over the complete genome sequencing 
of both the major vectors and parasites helped to have an 
access at genome-wide transcription profiles. The translated 
peptide or protein can be analyzed by western blot, ELISA 
or phenotypic expression (Fluorescence, refractoriness). 
Heterologous expression in transgenic mosquitoes could be 
characterized as following:
3.1. Heterologous or endogenous gene expression driven by an 
endogenous promoter
  A reporter gene driven by the endogenous promoter can be 
transformed into mosquitoes. By analyzing the expression 
of the reporter gene, the regulatory function of the promoter 
could be evaluated. Most of promoters, such as AgCP, AsVG, 
AaVgR, etc, are identified by such strategy (Table 1). For 
example, the genomic DNA fragments containing cis-acting 
promoter elements from the Maltase-like I (MalI) and 
Apyrase (Apy) genes were cloned as to direct the expression 
of the reporter gene, luciferase (luc)[8]. Analysis of 
transformed mosquito lines demonstrated that both the MalI 
and Apy promoter regions were capable of directing the 
expression of a reporter gene in the correct developmental- 
sex- and tissue-specific manner as observed for the 
respective endogenous genes. The result implies that those 
DNA sequences contain all of the necessary regulatory and 
control elements for a successful expression of molecules 
against parasite development or viral replication in the 
yellow fever mosquito, Aedes aegypti(Ae. aegypti) . In another 
study, an 800 bp fragment of AgApy directed expression 
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of a reporter gene in the salivary glands of transgenic 
An. stephensi[17]. Although the reporter gene product 
accumulated ectopically in the lobes of female salivary 
glands, the expression levels of these reporter genes were 
at low levels. The regulatory region of the vitellogenin (Vg) 
gene of Ae. aegypti were evaluated for its ability to express 
potential anti-pathogen factor, endogenous defensin, 
which acts as one of the major insect immune factor, in 
transgenic mosquitoes[18]. The result showed that high 
levels of transgenic defensin were ectopically expressed in 
the hemolymph of blood-fed female mosquitoes under the 
control of Vg promoter, persisting for 20-22 days after a 
single blood feeding. This represented the ability to engineer 
the genetically stable transgenic mosquito with an element 
of systemic immunity which is activated through the blood 
meal-triggered cascade rather than by infection.
3.2. Heterologous or endogenous gene expression driven by a 
heterologous promoter
  Most of the selective molecules, like EGFP or DsRed driven 
by 3伊P3 promoter, and effector molecules, like SM1 or PLA2 
driven by CP promoter, are expressed in this mode (Table 1). 
Heterologous promoters cloned from different species but in 
same genus, or from different genus, or even from different 
families, have been proved to be capable of driving the 
heterologous or endogenous gene expression in transgenic 
mosquitoes.
  Owing to the technical difficulty, transformation of 
An. gambiae, the principal vector of malaria in sub-
Saharan Africa, is not routine. An. stephensi, a vector of 
urban malaria in southern Asia, is often used to validate 
the function of An. gambiae cis-acting control DNA. The 
promoter of 毬2-tubulin, a gene transcribed selectively in 
the male gonads, isolated from An. gambiae, is used to drive 
EGFP expression in An. stephensi[9]. EGFP fluorescence was 
observed in the male gonads of the transgenic lines but not 
in adult female. In a similar study conducted in Ae. aegypti 
with the 毬2 orthologous gene, expression of a fluorescent 
reporter gene marked sperms were detected in spermathecae 
of inseminated females[19]. The observation that the 
毬2-tubulin promoter of An. gambiae has a tight sex-
specific expression pattern in An. stephensi argues that 
毬2-tubulin driven EGFP expression may serve as a robust 
and common genetic system to generate sexing strains in 
different mosquito species, in particular those belonging to 
the An. gambiae complex, but also other important disease 
vectors such as Aedes and Culex mosquitoes. In a recent 
study, the nanos (nos) gene was expressed in females 
and is localized in the oocytes which were responsible 
for determining the anterior-posterior axis in developing 
embryo. The nos orthologous gene of Ae. aegypti was able to 
control sex-and tissue-specific expression of exogenously 
derived MosI transposase encoding DNA[20]. Transgenic 
mosquitoes expressed transposase mRNA in abundance 
and exclusively in the female germ cells and in addition 
the transgene mRNA was deposited in developing oocytes 
and localized and maintained at the posterior pole during 
early embryonic development. Ae. aegypti and An. gambiae 
bear only a distant evolutionary relationship. Thus, it was 
important to predict whether the AgCP promoter, which 
does not contain any apparent sequence similarity to the 
AeCP promoter, would drive gut-specific expression in the 
Ae. aegypti gut. However, both promoters were able to drive 
robust expression of the reporter gene Luciferase, its mRNA 
and protein in a blood-inducible manner[6]. One significant 
difference was the induction of the AgCP promoter by a 
blood meal is rapid (3 h) in An. gambiae, but much slower 
(24 h) in Ae. aegypti. The Ae. aegypti carboxypeptidase 
promoter has also been proved to function well in An. 
gambiae and drive the CecA expression in the posterior 
midgut beginning 24 h after blood feeding [10].
  A GFP marker gene under the control of the promoter 
region of the Drosophila melanogaster act88F gene, a flight 
muscle-specific promoter, was inserted into the genome of 
Culex quinquefasciatus[21]. GFP expression in the transgenic 
mosquitoes was restricted to the flight muscle. The result 
indicated that Drosophila melanogaster promoter region can 
be used in mosquitoes, and other heterologous insects.
3.3. Expression level
  Expression levels of heterologous genes are crucial to their 
function. Many factors may affect the expression, such as 
the promoter, the coding sequence, the copy number and the 
insertion place. Robust salivary gland-specific transgene 
expression was shown in An. stephensi mosquito[22]. By 
comparison with purified DsRed protein commercially 
available, which was used as standard for quantification, 
the amount of DsRed protein was calculated to be 25 ng 
per pair of salivary glands. This represents approximately 
5% of total salivary gland protein level, and over 1 000-
fold higher level of expression than salivary gland-specific 
transgene expression reported by others[8,17]. Moreira et al 
reported a robust gut-specific gene expression in transgenic 
Ae. aegypti mosquitoes[6]. Based on the comparison of the 
signal of the transgenic luciferase protein on Western blots 
with that of a reference enzyme, it can be calculated that 
approximately 2 ng of luciferase protein accumulated per 
gut at 24 h after a blood meal. It is therefore feasible that 
a protein expressed from the carboxypeptidase promoter 
will accumulate at sufficiently high concentration in the 
midgut lumen to act as an effective inhibitor of Plasmodium 
development.
  However, the levels of heterologous expression in many 
reports are not high even very low, so that they cannot be 
detected at protein level. Kim et al reported the ectopic 
expression of a cecropin transgene in An. gambiae[10]. The 
inability to detect cecA peptide by immunofluorescence 
suggests that the peptide may be absent or present at very 
low levels in the posterior midgut. The author's laboratory 
had successfully transformed a scFv anti-Pfs25 gene into 
An. stephensi. The RT-PCR and northern blot showed that 
the transgene transcribed well but western blot did not 
detect the protein (Unpublished data). Efforts to increase 
the levels of effectors either by manipulating transcription 
levels or protein turnover rates might result in an increase in 
antiparasitic activity.
3.4.Stability of mRNA or protein
  Although the expression pattern of heterologous genes 
is generally consistent with that of the endogenous, some 
differences have also been noticed, for example, the stability 
of the expressed mRNA or protein. Yoshida and Watanabe 
showed that promoters of anopheline antiplatelet protein 
(AAPP) could drive the Discosoma sp. red fluorescent protein 
(DsRed) for expressing abundantly in salivary gland[22]. 
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However, unlike the endogenous aapp mRNAs, expression 
of the DsRed mRNA reached a high level at as early as 24h 
after a blood meal and kept the expression level for next 
24h. One explanation of this abundance of the DsRed mRNA 
may be due to a high stability of its mRNA. High levels of 
transgenic defensin were accumulated in the hemolymph 
of blood fed female mosquitoes, persisting for 20-22 days 
after a single blood feeding[18]. This stability of the transgene 
product may make it an effective means of controlling 
pathogen infection throughout of the adult life of a mosquito. 
The mechanism of the longer stability still remains unclear.
3.5. Expression specificity 
  The specificity of heterologous expression includes spatial 
specificity and temporal specificity; both are determined 
by the function of promoters. Various promoters exhibit 
different characteristics of expressions (Table 1). For 
example, the promoters of carboxypeptidase and adult 
peritrophic matrix protein 1 can drive heterologous 
expression in midgut of female mosquito after a blood meal. 
Vitellogenin promoter can drive heterologous expression 
in fat bodies of female mosquito after a blood meal. The 
promoters of anopheline antiplatelet protein (AAPP) and 
maltase-like I can efficiently drive heterologous expression 
in salivary glands of female mosquitoes after blood 
meal[14]. Compared with the carboxypeptidase (midgut) 
and vitellogenin (fat body) promoters that are activated 
immediately (<3 h) and around 24 h, respectively, after a 
blood meal[7,23], some of salivary gland specific promoters 
may be activated as late as around 48 h after a blood meal 
to stock the saliva for the next blood feeding. Recently, 
the promoters driven heterologous expression specific in 
gonad[9] and ovary [24] have been identified, providing useful 
tools for the implementation of transgenic strategy.
 
Table 1 
Heterologous genes expressed in mosquitoes.  　	 　   
Transformation Vector Expression Specificity Function
Genes Promoter TE Species Sex Tissue Stage Marker Effector Fitness
EGFP1 actinP Minos An. stephensi Both Muscle Constitutive Yes No NA
EGFP2 actinP Minos An. stephensi Both Muscle Constitutive Yes No Yes
EGFP3 毬2-tubP piggyBac An. stephensi Male Gonads Constitutive Yes No NA
EGFP4 3xP3 phi C31 Ae. aegypti Both Eyes Constitutive Yes No NA
EGFP5 act88FP Hermes Cx. quinque Both Muscle Constitutive Yes No NA
EGFP6 actinP Hermes Cx. quinque Both Muscle Constitutive Yes No NA
DsRed7 aappP Minos An. stephensi Female SG Vitellogenic Yes No NA
DsRed3 3xP3 piggyBac An. stephensi Both Eyes Constitutive Yes No NA
DsRed4 3xP3 phi C31 Ae. aegypti Both Eyes Constitutive Yes No NA
DsRed8 AaVgRP piggyBac Ae. aegypti Female Ovary Vitellogenic Yes No NA
Luciferase9 AeCP Hermes Ae. aegypti Female Midgut Vitellogenic Yes No NA
Luciferase9 AgCP Mos1 Ae. aegypti Female Midgut Vitellogenic Yes No NA
Luciferase9 MalIP Hermes Ae. aegypti Female SG PBM Yes No NA
Luciferase9 ApyP Hermes Ae. aegypti Female SG PBM Yes No NA
CFP10 AsVg1P piggyBac An. stephensi Female Fat body Vitellogenic Yes No NA
SM111 AgCP piggyBac An. stephensi Female Midgut PBM No Yes No
PLA211 AgCP piggyBac An. stephensi Female Midgut PBM No Yes NA
PLA212 AgAper1P piggyBac An. stephensi Female Midgut PBM No Yes Yes
DefA13 AeVg Hermes Ae. aegypti Female Fat body PBM Yes Yes NA
DefA13 AeVg piggyBac Ae. aegypti Female Fat body PBM No NA NA
CecA14 AeCP piggyBac An. gambiae Female Midgut PBM No Yes NA
  1: Reference 5; 2: Reference 32; 3: Reference 9; 4: Reference 15; 5: Reference 21; 6: Reference 36; 7:Reference 22; 8: Reference 24; 
9: Reference 6; 10: Reference 8; 11: Reference 25; 12: Reference 26; 13: Reference 28; 14: Reference 7; 15: Reference 10.
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4. Effect of the expression
  The recent generation of genetically transformed 
mosquitoes has raised hopes for the production of mosquito 
strains that are unable to transmit various parasites or 
viruses. There are a number of examples of exogenous 
molecules that, when expressed or introduced into 
mosquitoes, are able to block the transmission of pathogens. 
Endogenously derived, tissue specific promoters are used 
to drive the expression of anti-parasitic effector molecules 
in mosquitoes to minimize potential fitness costs and to 
maximize parasite blocking.
4.1. Selective marker
  The expression products of fluorescent genes, such as 
EGFP, DsRed, CFP and Luciferease, are often used as the 
selective marker to screen the transgenic mosquitoes. In 
2000, Catteruccia et al reported the first reliable system of 
germ line transformation of the malaria vector using EGFP. 
Their results showed that EGFP was as a reliable marker 
for An. stephensi, as for other insect species. The coding 
sequences of fluorescent genes are usually driven by a 
tissue specific promoter like 3xP3, so that the transgenic 
mosquitoes can be easily identified if the fluorescence is 
observed in specific tissue (eyes). The 3xP3 promoter has 
been used in a wide variety of insects ranging four orders.
  The expression of fluorescent genes can be used to analyze 
the function of promoter. The appearance of fluorescence 
at different times and tissues indicates the regulatory 
functions of the promoters. The functional characterization 
of AsVg1, the promoter of the vitellogenin gene of An. 
stephensi was observed by the expression of cyan fluorescent 
protein (CFP)[25]. The results showed that CFP expressed 
specifically in fat bodies of female mosquitoes after a blood 
meal, indicating that the AsVg1 promoter could serve as a 
candidate for controlling the expression of anti-pathogen 
effector molecules in An. stephensi. The following study 
confirmed that AsVg1 could direct a scFv gene expression 
in a sex-, stage- and tissue-specific manner in transgenic 
An. stephensi (unpublished data).
  The disadvantage for fluorescence as a selective marker 
is the existence of plausible autofluorescence in some 
insects. Green and red antofluorescence was detected in the 
accessory glands of both transgenic and wild-type males. 
A weak green autofluorescence was also seen in the thorax 
of the wild-type mosquitoes[22]. Given the confounding 
autofluorescence, a specific detection of the fluorescent 
expression, such as RT-PCR or western blot, may be needed 
to verify the engineered expression.
4.2. Anti-pathogen
  The identification of an "effector gene" able to interfere 
with the development of the parasite in the mosquito is 
an essential prerequisite for the generation of a refractory 
mosquito. Ideally, the effector gene expression should 
kill the parasite or block its further development without 
imposing a fitness load on mosquito. Several attempts 
have been made to identify such an effector gene. The first 
experiment of blocking malaria parasite transmission using 
transgenic approaches was reported in 2002[26] based on 
a 12-amino-acid peptide, termed SM1 for salivary gland 
and midgut binding was selected from a bacteriophages 
displaying library[13]. A synthetic gene [termed AgCP(SM1)4] 
consisting of four SM1 units joined by 4-amino-acid linkers 
attached to the CP signal sequence and driven by the gut-
specific and blood-inducible An. gambiae carboxypeptidase 
(AgCP) promoter was constructed and then inserted into 
a piggyback vector and transformed into the germ line of 
the mosquito An. stephensi[26]. The results showed that SM1 
expressed specifically in female transgenic mosquito midgut 
after blood meal induction and the expressed SM1 tetramer 
binds to the luminal surface of the midgut, inhibiting 
parasite-epithelium interactions and midgut invasion. 
  In the same year, transgenic An. stephensi mosquitoes that 
expressed the bee venom phospholipase A2 (PLA2) gene 
with AgCP as the promoter were reported[27]. Northern blot 
analysis indicated that the PLA2 mRNA was specifically 
expressed in the guts of transgenic mosquitoes with peak 
expression at 4 h after blood ingestion. Western blot and 
immunofluorescence analysis detected PLA2 protein in 
the midgut epithelia of transgenic mosquitoes from 8 to 
24 h after a blood meal. Importantly, transgene expression 
reduced Plasmodium berghei oocyst formation by 87% on 
average and greatly impaired transmission of the parasite 
to naive mice. The results indicate that PLA2 may be used 
as an additional effector gene to block the development of 
the malaria parasite in mosquitoes. In 2005, the function 
of phospholipase A2 (PLA2) was further analyzed with the 
regulatory gene of An. gambiae adult peritrophic matrix 
protein 1 (AgAper1) promoter[28]. The data displayed that 
AgAper1 regulatory elements were sufficient to promote 
the accumulation of PLA2 in midgut epithelial cells before 
a blood meal and its release into the lumen upon blood 
ingestion. Plasmodium berghei oocyst formation was reduced 
by 80% in transgenic mosquitoes.
  Single-chain antibody fragments (scFv) directed against 
parasite ligands and expressed as a single gene have shown 
high efficacy in transmission blockage. An scFv against 
the circumsporozoite protein (N2 scFV), which is abundant 
on the surface of sporozoites and essential for gliding 
motility and the invasion of salivary glands, was expressed 
in Ae. aegypti through engineered Sindbis viruses[12]. 
After infection, the numbers of P. gallinaceum sporozoites 
detected in the salivary glands were reduced by 99%. ScFvs 
targeting parasite ligands expressed at earlier sporogonic 
stages (e.g. the ookinete surface proteins P28 and P25) are 
additional candidates for transmission blocking. Some have 
proven efficacy in reducing parasite numbers when provided 
to mosquitoes through the blood meal.
  Immunity effector genes encoding antimicrobial peptides 
(AMPs) have been shown to be effective against Plasmodium 
in in vitro assays[29]. Transgenic mosquitoes carrying either 
Vg-DefA or Vg-CecA transgenes exhibited resistance to 
the gram-negative bacterium Enterobacter cloacae that 
was nearly twice as high as that of the wild-type mosquito. 
Further studies showed that two independent transgenic 
Ae. aegypti strains over-expressing Defensin A inhibited 
oocyst growth of P. gallinaceum by 65%-70%. Similarly, 
transgenic over-expression of endogenous Cecropin A or 
Defensin A in the fat body of adult Ae. aegypti mosquitoes 
have led to strong inhibition of P. gallinaceum sporozoite 
development. Scorpine, a 75 amino acid peptide isolated 
from Pandinus imperator  venom, whose structure 
resembles a hybrid between a defensin and a secropin 
exhibits antibacterial activity and inhibits the sporogonic 
development of murine malaria parasite. The recombinantly 
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expressed scorpine (RScp) in An. gambiae cells under the 
control of An. gambiae serpin promoter showed antibacterial 
activity against Bacillus subtilis and Klebsiella pneumoniae 
and 98% mortality in sexual stages of Plasmodium berghei 
and 100% reduction in P. falciparum parasitemia[30]. Two 
independent lines of transgenic An. gambiae were created 
using a piggyback gene vector containing the An. gambiae 
cecA cDNA driven by the CP promoter originated from Ae. 
aegypti[10]. Infection with Plasmodium berghei resulted in 
a 60% reduction in the number of oocysts in the transgenic 
mosquitoes compared with non-transgenic mosquitoes. 
Manipulating the innate immune system of mosquitoes can 
negatively affect their capacity to serve as hosts for the 
development of disease-causing microbes. This was the first 
report of genetically engineered Plasmodium refractoriness 
in An. gambiae.
4.3. Fitness load
  It has been proposed that transgenic organisms are less 
fit because they are evolutionary novelties with reduced 
viability[31]. Transgenic mosquitoes typically express 
multiple heterologous genes; for example, a fluorescent 
marker and an anti-pathogen effector protein. The 
accumulation of foreign proteins might be toxic to the 
cells in which they are expressed. Proteins expressed in 
a restricted cell type are less likely to have an impact on 
fitness than ubiquitously expressed proteins. For instance, 
fluorescent protein expressed in the eye does not appear 
to affect fitness. However, in another study[32], factors 
influencing fitness were investigated in cage experiments 
with four lines of transgenic An. stephensi, in which EGFP 
was expressed ubiquitously under the control of actin5C 
promoter of Drosophila melanogaster (actinP). The results 
indicate direct costs of the introduced transgenic in at least 
three out of four lines, as well as an apparent cost of the 
inbreeding involved in making transgenic homozygotes. 
The author suggested that it is highly desirable to construct 
engineered lines that are substantially out bred.
  Catteruccia et al[32] have shown that homozygous transgenic 
An. stephensi has lower fitness than wild type. Similar 
studies have been characterized in transgenic Ae. aegypti 
also. Reduced fitness observed in the transgenic population 
may be caused due to the presence of recessive genes near 
transgene insertion point. Other possible explanations 
for this lower fitness suggests the homozygous expression 
(hitchhiking effect), over-expression of a foreign protein (eg: 
GFP) in somatic tissues and insertional mutagenesis[33].   
  The nature of the expressed protein itself is a crucial factor 
for fitness[33]. For example, although no effect on fitness 
was observed for mosquitoes expressing the 12 amino acid 
peptide SM1[26], mosquitoes expressing the phospholipase 
A2 (PLA2) were clearly less fit and less fertile than wild 
type[28]. In a recent study conducted by Chaoyang Li et al[34] 
compared the fitness of hemizygous transgenic mosquitoes 
which secrete into the midgut either of two effector proteins, 
SM1 and phospholipase A2 under the control of the blood 
inducible CP promoter. They showed that heterozygous SM1 
expressing transgenic mosquitoes exhibited no detectable 
fitness load, whereas PLA2 expressing mosquitoes showed 
reduced fitness and midgut damage presumably as a result 
of phospholipase enzymatic activity. The SM1 transgenic 
mosquitoes when fed on mice infected with gametocyte 
producing Plasmodium berghei exhibited a fitness advantage 
over sibling non-transgenic mosquitoes, and showed higher 
fecundity and lower mortality in them[35]. At the same time 
this fitness load was not visible when fed on non infected 
mice. These suggest the existence of a strong selective 
advantage between the transgenic and non-transgenic lines.
  The measure of fitness of these transgenic mosquitoes 
were studied recently[34] and the fitness load of three 
independently derived homozygous transgenic lines were 
attributed to lower mating success, possibly, derived from 
hitchhiking effect or insertional mutagenesis. Several 
advantages of using transgenic lines for future genetic 
approach to control most of the vector-born diseases are 
enlighted. These include stronger and more effective gene 
expression, ease in mass rearing and eventual field release 
and more efficient transgene introgression in the field. 
However, the use of homozygous mosquitoes encountered 
a basic problem of showing hitchhiking effects of potential 
recessive deleterious mutations near the site of transgene 
insertion. Hence, these findings highlights the need to use 
effector genes that minimize mosquito fitness costs and 
select lines with integration events that do not reside near 
loci which confer high fitness costs when homozygous. This 
fitness advantage has important implications for devising 
malaria control strategies by means of genetic modification 
of mosquitoes.
5. Conclusion
  Mosquito transmitted diseases including malaria 
prevalence in the developing world is increasing, and 
there is an immediate need to develop novel strategies 
for disease control. Based upon the precedents of 
controlling mainly agricultural pests, and the potential 
of recent biotechnological advances, the concept of 
genetic control of mosquito populations is attractive. 
The research on heterologous expression in transgenic 
mosquitoes has progressed much in recent years. The 
expression of fluorescent proteins facilitates the screening 
of transformants and functional analysis of the regulatory 
regions. The identification of a growing number of 
effector molecules brings us closer to the promise of a 
genetic strategy to control the transmission of mosquito-
borne diseases. We identified several critical gaps in our 
knowledge and technology. Firstly, the expression levels 
of heterologous genes in transgenic mosquitoes are usually 
low, which might affect their ability to block transmission. 
Secondly, there is yet no complete inhibition of transmission 
in transgenic mosquitoes. Novel effector molecules with 
more effective anti-pathogen function need to be developed. 
Thirdly, multi-effector molecules need to be expressed in 
the same transgenic mosquitoes, which might increase the 
effect of anti-pathogen as well as decrease the possibility of 
mosquito resistance to the effectors. 
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